All News #Library
Biotech
Dizal`s ZEGFROVY Demonstrates Strong Antitumor Activity
27 Mar 2026 //
PR NEWSWIRE
Dizal`s Zegfrovy Adds More Pressure To J&J`s Rybrevant
23 Mar 2026 //
FIERCE PHARMA
Dizal`s zegfrovy Gets FDA Approval for EGFR Exon 20 Mutations
02 Jul 2025 //
PR NEWSWIRE
Dizal to Present Data in Hematologic Malignancies and Lung Cancer
24 Apr 2025 //
PR NEWSWIRE
Dizal Announces Presentations at 2025 ASCO Annual Meeting
01 Apr 2025 //
PR NEWSWIRE
Dizal`s Golidocitinib with Anti-PD-1 Promising in Lung Cancer
20 Mar 2025 //
PR NEWSWIRE
Dizal`s Data on DZD8586 in B-cell Non-Hodgkin Lymphoma at ASH
09 Dec 2024 //
PR NEWSWIRE

Market Place
Sourcing Support